Allostasis and addiction: Role of the dopamine and corticotropin-releasing factor systems
Highlights
► The opponent process theory postulates that drugs trigger two opposing motivational process. ► The a-process has fast onset and offset and the b-process is opposite, slower to start and last longer. ► Decreased dopaminergic function in the NAC and CeA mediate the habituation of the a-process. ► Activation of the CRF systems in the CeA and VTA mediates the increase in b-process in dependent subjects. ► Interaction between the dopamine and CRF systems may represent the opponent-process mechanisms of drug withdrawal.
Section snippets
Allostasis
Allostasis, originally conceptualized to explain persistent morbidity of arousal and autonomic function, is defined as the process of achieving stability through physiological or behavioral change [1], [2]. Allostasis involves a feed-forward mechanism rather than the negative feedback mechanisms of homeostasis, with continuous re-evaluation of need and continuous readjustment of all parameters toward new set points. Thus, the very physiological mechanism that allows rapid responses to
Drug addiction
Drug addiction is a chronically relapsing disorder characterized by compulsion to seek and take the drug, loss of control in limiting drug intake, and emergence of a negative emotional state, reflecting a motivational withdrawal syndrome, when access to the drug is prevented (defined here as dependence; [10]). Clinically, the occasional but limited use of a drug with the potential for abuse or dependence is distinct from escalated drug intake and the emergence of a chronic drug-dependent state.
Motivation, opponent process, and addiction
Motivation is a state that can be defined as a “tendency of the whole animal to produce organized activity” [17]. The concept of motivation was linked inextricably with hedonic, affective, or emotional states in addiction in the context of temporal dynamics by Solomon's opponent process theory of motivation. [18] postulated that hedonic, affective, or emotional states, once initiated, are automatically modulated by the central nervous system with mechanisms that reduce the intensity of hedonic
Role of the dopaminergic system in the motivational response that underlies the opponent process of drug abuse
The mesolimbic dopaminergic system is formed by the dopaminergic cell bodies in the ventral tegmental area (VTA) and their projections to the ventral striatum. The VTA also possesses a population of γ-aminobutyric acid (GABA) neurons that provide inhibitory inputs to dopamine cells and influence other structures, such as the pedunculopontine tegmental nucleus and glutamatergic neurons [21]. The VTA receives its main excitatory glutamatergic and cholinergic inputs from the ventromedial
Role of the corticotropin-releasing factor system in the motivational response that underlies the opponent process of drug abuse
Within the domain of changes in reward function, the primary deficit is hypothesized to be a neuroadaptational shift in how rewards are processed. More specifically, a loss of positive reinforcement and a recruitment of negative reinforcement are hypothesized to occur within a specific basal forebrain area termed the extended amygdala. The extended amygdala has been identified by neuroanatomical studies [53], [54] as a separate entity within the basal forebrain and has been hypothesized to be a
Interaction between the dopamine and corticotropin-releasing factor systems
The mesolimbic dopaminergic and extended amygdala CRF systems have long been studied independently and often viewed as mutually exclusive in the drug addiction field. However, recent work has demonstrated that these two systems can powerfully interact with each other, suggesting that dysregulation of this interaction may be lead to the development of drug dependence and relapse. Very few studies have investigated the role of dopamine in CRF release in the extended amygdala, despite the fact
Conclusions
Acute withdrawal from drugs of abuse produces opponent process-like changes in reward neurotransmitters in specific elements of reward circuitry associated with the mesolimbic dopaminergic system and recruitment of the extended amygdala and CRF stress systems that motivationally oppose the acute hedonic effects of drugs of abuse. Such changes in the dopamine and CRF these brain systems associated with the development of motivational aspects of withdrawal are hypothesized to be a major source of
Acknowledgments
This is publication number 21324 from The Scripps Research Institute. This work was supported by the National Institutes of Health grant DA04398, DA10072, DA04343, and DA023597 from the National Institute on Drug Abuse, AA08459, and AA06420 from the National Institute on Alcohol Abuse and Alcoholism, and the Pearson Center for Alcoholism and Addiction Research. The authors would like to thank Michael Arends for his help with manuscript preparation.
References (126)
- et al.
Biological basis of stress-related mortality
Soc Sci Med E
(1981 Feb) - et al.
Drug addiction, dysregulation of reward, and allostasis
Neuropsychopharmacology
(2001) - et al.
Are subordinates always stressed? A comparative analysis of rank differences in cortisol levels among primates
Horm Behav
(2003 Jan) - et al.
Allostatic load as a predictor of functional decline. MacArthur studies of successful aging
J Clin Epidemiol
(2002) - et al.
Allostasis: a theoretical framework for understanding and evaluating perinatal health outcomes
J Obstet Gynecol Neonatal Nurs
(2007) - et al.
Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity
Neuroscience
(1999) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area
Brain Res Rev
(1993)- et al.
Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity
Brain Res
(1987) Action of drugs of abuse on brain reward systems
Pharmacol Biochem Behav
(1980)The role of reward pathways in the development of drug dependence
Pharmacol Ther
(1987)
Brain reward circuitry: insights from unsensed incentives
Neuron
The neural basis of drug craving: an incentive-sensitization theory of addiction
Brain Res Rev
Dopamine partial agonist reverses amphetamine withdrawal in rats
Neuropsychopharmacology
Cannabinoid transmission and reward-related events
Neurobiol Dis
Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration
Brain Res
New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata
Neuroscience
Neuroscience of addiction
Neuron
Neuropeptide Y in the stria terminalis: evidence for an amygdalofugal projection
Brain Res
Topography of projections from amygdala to bed nuclei of the stria terminalis
Brain Res Rev
Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat
Peptides
Axon terminals containing tyrosine hydroxylase- and dopamine-β-hydroxylase immunoreactivity form synapses with galanin immunoreactive neurons in the lateral division of the bed nucleus of the stria terminalis in the rat
Brain Res
Chemoanatomic compartments in the human bed nucleus of the stria terminalis
Neuroscience
CRH signalling in the bed nucleus of the stria terminalis is involved in stress-induced cardiac vagal activation in conscious rats
Neuropsychopharmacology
Bed nucleus of the stria terminalis: site for the antinatriorexic action of tachykinins in the rat
Pharmacol Biochem Behav
Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake
Pharmacol Biochem Behav
Corticotropin releasing factor, stress and behavior
Semin Neurosci
Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal
Brain Res
Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse
Biol Psychiatry
Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine self-administration in rats
Neuropsychopharmacology
Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse
Pharmacol Ther
Effect of 6-hydroxydopamine on neuropeptide Y and corticotropin-releasing factor expression in rat amygdala
Neuroscience
Dopamine receptor-mediated regulation of corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus
Brain Res
Intrinsic neuronal plasticity in the juxtacapsular nucleus of the bed nuclei of the stria terminalis (jcBNST)
Prog Neuropsychopharmacol Biol Psychiatry
Corticotropin-releasing factor projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area
Neuroscience
Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei: potential implication for arousal and attention
Neuroscience
Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons
Neuron
Corticotropin-releasing factor receptor type 1, but not type 2, in the ventromedial hypothalamus modulates dopamine release in female rats
Pharmacol Biochem Behav
Regulation of somatodendritic dopamine release by corticotropin-releasing factor via the inhibition of voltage-operated Ca2 + channels
Neurosci Lett
Allostasis: a new paradigm to explain arousal pathology
Social allostasis: anticipatory regulation of the internal milieu
Front Evol Neurosci
Exploring a new concept of cumulative biological risk: MacArthur studies of successful aging
Proc Natl Acad Sci USA
Price of adaptation: allostatic load and its health consequences. MacArthur studies of successful aging
Arch Intern Med
“Weathering” and age patterns of allostatic load scores among blacks and whites in the United States
Am J Public Health
Drug abuse: hedonic homeostatic dysregulation
Science
Stress, adaptation, and disease: allostasis and allostatic load
Cumulative risk, maternal responsiveness, and allostatic load among young adolescents
Dev Psychol
Allostatic load in women with and without PTSD symptoms
Psychiatry
Addiction and the brain antireward system
Annu Rev Psychol
Allostatic view of motivation: implications for psychopathology
Textbook of psychology
Cited by (136)
A neuroinflammatory compulsivity model of anorexia nervosa (NICAN)
2024, Neuroscience and Biobehavioral ReviewsAllosteric modulation of serotonin and dopamine transporters: New insights from computations and experiments
2024, Current Research in PhysiologyHPA axis function in alcohol use disorder: A systematic review and meta-analysis
2023, Addiction NeuroscienceTobacco Use Disorder
2022, Medical Clinics of North America